Nidan Laboratories and Healthcare (NSE:NIDAN) Total Liabilities: ₹147.6 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.45
View Full Analysis

What is Nidan Laboratories and Healthcare Total Liabilities?

Nidan Laboratories and Healthcare NSE:NIDAN +2.28% 67 Total Liabilities is ₹147.6 Mil as of Mar. 2025. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100.

Nidan Laboratories and Healthcare's Total Liabilities for the quarter that ended in Mar. 2025 was ₹147.6 Mil.

Nidan Laboratories and Healthcare's quarterly Total Liabilities declined from Mar. 2024 (₹163.45 Mil) to Sep. 2024 (₹161.44 Mil) and declined from Sep. 2024 (₹161.44 Mil) to Mar. 2025 (₹147.58 Mil).

Nidan Laboratories and Healthcare's annual Total Liabilities increased from Mar. 2023 (₹149.63 Mil) to Mar. 2024 (₹163.45 Mil) but then declined from Mar. 2024 (₹163.45 Mil) to Mar. 2025 (₹147.58 Mil).

Nidan Laboratories and Healthcare Total Liabilities Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare Total Liabilities Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Liabilities
Get a 7-Day Free Trial 404.09 225.80 149.63 163.45 147.58

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 149.63 0.00 163.45 161.44 147.58
NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nidan Laboratories and Healthcare Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nidan Laboratories and Healthcare's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=101.958+(38.95+0.73999999999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+5.933+0)
=147.6

Total Liabilities=Total Assets (A: Mar. 2025 )-Total Equity (A: Mar. 2025 )
=829.411-681.83
=147.6

Nidan Laboratories and Healthcare's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=101.958+(38.95+0.73999999999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+5.933+0)
=147.6

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=829.411-681.83
=147.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹147.6 Mil mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Total Liabilities of ₹147.6 Mil as of Mar. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nidan Laboratories and Healthcare and its competitors.
Is Nidan Laboratories and Healthcare's Total Liabilities too high?
Nidan Laboratories and Healthcare's current Total Liabilities is ₹147.6 Mil. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Total Liabilities compare to TMO and DHR?
Nidan Laboratories and Healthcare's Total Liabilities of ₹147.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current Total Liabilities is ₹147.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a current Total Liabilities of ₹147.6 Mil. The current Total Liabilities is ₹147.6 Mil. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Total Liabilities is ₹147.6 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.45
Price